Skip to the answer

Serdexmethylphenidate and Dexmethylphenidate Uses, Dosage, Side Effects and Interactions

Brand name
Azstarys

Azstarys was the first serdexmethylphenidate and dexmethylphenidate product the FDA approved, in May 2021. No generic is listed as capsules.

First generic of Azstarys: our estimate, December 2037

Serdexmethylphenidate and dexmethylphenidate is a CNS stimulant combination used to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Serdexmethylphenidate and DexmethylphenidateType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Serdexmethylphenidate and Dexmethylphenidate in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Azstarys is a long-acting stimulant for ADHD in people 6 and older, from the methylphenidate family that is a usual first choice, pairing quick-acting dexmethylphenidate with serdexmethylphenidate, a prodrug the body slowly turns into the same active drug, to raise dopamine and norepinephrine activity through the day; on the market since about 2021, it is not yet available as a generic. Most people tolerate it about as well as other methylphenidate medicines, mainly noticing a smaller appetite and trouble sleeping. Its boxed warning covers abuse, misuse and addiction, so take it exactly as prescribed, keep it locked up and never share it.

Key Takeaways From the HelloPharmacist Team

  • Take it once in the morning; if swallowing is hard, open the capsule onto applesauce or into water and finish within 10 minutes.
  • Expect a dose review after the first week, when it may be raised or lowered depending on how it works and feels.
  • Expect blood pressure and heart rate checks at follow-up visits, plus regular height and weight checks for children taking it.
  • Get emergency care right away for chest pain, shortness of breath or fainting, and call the prescriber about hallucinations or extreme mood changes.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Serdexmethylphenidate and Dexmethylphenidate.

Azstarys has a high potential for abuse, misuse, and addiction. Like other CNS stimulants, it can be misused — especially if taken at higher doses or by methods other than swallowing (such as snorting or injecting). This misuse can lead to overdose and death. Anyone taking Azstarys should be assessed for their risk of abuse before starting treatment, and monitored throughout. Keep it stored safely, preferably locked up, never share it with anyone else, and dispose of any unused medication properly. Signs of misuse include taking more than prescribed, using it to get high, or craving the drug.

Read the full warning on DailyMed →

Serdexmethylphenidate and Dexmethylphenidate by the Numbers

Strengths
3
in one form
Makers and packagers
1
Earliest FDA record
2021
Rank by Medicaid prescriptions
#422 of 1,682 drugs
More prescriptions than 74% of the 1,682 drugs we measure
170,163 prescriptions, Q1–Q4 2025

Patient Information Guide for Serdexmethylphenidate and Dexmethylphenidate

What It’s Used For

Serdexmethylphenidate and dexmethylphenidate is a CNS stimulant combination approved for the following use:

  • Azstarys (oral capsule) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older, including children, adolescents, and adults.
  • Azstarys is not recommended for children under 6, as this age group experiences greater drug exposure and a higher rate of adverse reactions, such as weight loss, compared to older patients at the same dose.

How It Works

Serdexmethylphenidate is a prodrug — an inactive form that the body converts into the active medicine, dexmethylphenidate, primarily in the lower gastrointestinal tract. Dexmethylphenidate is a CNS stimulant that blocks the reuptake (reabsorption) of two brain chemicals, norepinephrine and dopamine, and also promotes their release. This raises the levels of both chemicals in the synaptic space between nerve cells. Exactly how this translates to ADHD symptom improvement is not fully understood.

Drug Class

Drug Class

  • Central Nervous System Stimulant from dexmethylphenidate
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Serdexmethylphenidate and Dexmethylphenidate has two active ingredients, so each class says which one it comes from.

Drug Class

Established Pharmacologic Class (EPC)
  • Central Nervous System Stimulant from dexmethylphenidate

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Serdexmethylphenidate and Dexmethylphenidate in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)
  • Central Nervous System Stimulation from dexmethylphenidate

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Serdexmethylphenidate and Dexmethylphenidate in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Centrally acting sympathomimetics

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Azstarys is taken orally once every morning, with or without food. Eating does slow the time it takes to reach peak levels in the blood, but does not meaningfully change the overall amount absorbed.

The capsule can be swallowed whole or opened and mixed into water or applesauce — any mixture must be consumed immediately (within 10 minutes) and cannot be stored.

  • Azstarys is always dosed once daily in the morning.
  • It is not interchangeable milligram-for-milligram with other methylphenidate products — always follow your prescriber's specific dose instructions.
  • If symptoms worsen or side effects are bothersome, talk to your prescriber before making any changes.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

ADHD (attention deficit hyperactivity disorder)

Adults and teens 13 to 17 years old · Starting dose Starting dose 39.2 mg serdexmethylphenidate/7.8 mg dexmethylphenidate once daily in the morning

Good to know

Administer with or without food

Adults and teens 13 to 17 years old · After one week Usual dose 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily Highest dose 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily
  • Increase to 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily after one week, depending on response and tolerability
Children 6 to 12 years old · Starting dose Starting dose 39.2 mg serdexmethylphenidate/7.8 mg dexmethylphenidate once daily in the morning

Good to know

Administer with or without food

Children 6 to 12 years old · After one week Highest dose 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily
  • May be increased to 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate per day, or decreased to 26.1 mg serdexmethylphenidate/5.2 mg dexmethylphenidate per day, after one week, depending on response and tolerability

See the Full Dosing Instructions on DailyMed →

Side Effects

The most commonly reported side effects with methylphenidate products include:

Common side effects

  • Decreased appetite
  • Trouble sleeping (insomnia)
  • Nausea or vomiting
  • Stomach pain or upset stomach
  • Weight loss
  • Irritability or mood swings
  • Increased heart rate or blood pressure
  • Dizziness
  • Anxiety or irritability

When to get medical help

  • Chest pain, shortness of breath, or fainting — seek emergency care right away
  • Signs of psychosis or mania: hallucinations, delusions, or extreme mood changes — call your doctor
  • Painful or prolonged erections (priapism) — seek immediate medical attention
  • Numbness, coldness, or color changes in fingers or toes (signs of Raynaud's phenomenon) — tell your doctor
  • Children not growing or gaining weight as expected — discuss with your doctor
  • Signs of abuse or addiction — talk to your prescriber
  • Eye pain or vision changes — contact your doctor promptly
  • New or worsening tics, or worsening Tourette's syndrome — tell your doctor

More serious reactions — including chest pain, hallucinations, signs of psychosis or mania, painful erections, or severe allergic reactions — require prompt medical attention. In children, slowed growth in height and weight has been observed with long-term use and should be monitored by the prescriber.

Warnings and Precautions

  • Abuse, misuse, and addiction: Azstarys is a federally controlled stimulant with a high potential for abuse. Misuse — especially snorting or injecting — can cause overdose and death. Store it securely, never share it, and dispose of leftovers properly.
  • Heart risks: Sudden death has been reported in people with pre-existing structural heart problems taking CNS stimulants. Azstarys should not be used in patients with serious heart disease. It also raises blood pressure and heart rate, so regular monitoring is needed for everyone.
  • Psychiatric effects: Azstarys can trigger or worsen psychosis, hallucinations, or mania — even in people with no prior psychiatric history. Patients with bipolar disorder or a family history of mental illness should be carefully screened before starting.
  • Growth suppression in children: Long-term use has been linked to lower-than-expected gains in height and weight in pediatric patients. Height and weight should be tracked regularly, and treatment may need to be paused if growth is significantly affected.
  • Priapism: Prolonged, painful erections have been reported in both adults and children on methylphenidate. Seek immediate medical help if this occurs.
  • Peripheral vasculopathy (poor circulation): Raynaud's phenomenon — numbness, color changes, or ulcers in the fingers or toes — has been reported. Report any such changes to your doctor.
  • Eye pressure: Azstarys has been linked to increased intraocular pressure and angle-closure glaucoma. Patients with glaucoma or significant farsightedness should be evaluated by an eye doctor.
  • Tics and Tourette's syndrome: Azstarys can trigger or worsen motor or verbal tics. Patients should be evaluated before starting treatment and monitored throughout.

Interactions

Azstarys can interact with several medications — always tell your prescriber and pharmacist everything you take:

  • MAOIs (e.g., phenelzine, selegiline, tranylcypromine): Combining with Azstarys can trigger a hypertensive crisis — a sudden, dangerous spike in blood pressure that can be fatal. Azstarys must never be taken with an MAOI, or within 14 days of stopping one.
  • Blood pressure medications (antihypertensives): Azstarys can blunt the effectiveness of these drugs. Blood pressure should be monitored more closely, and the antihypertensive dose may need adjustment.
  • Halogenated anesthetics (used during surgery): This combination can cause sudden, dangerous increases in blood pressure and heart rate. Azstarys should be avoided on the day of any surgical procedure requiring anesthesia.
  • Risperidone: When used together with methylphenidate, dosage changes in either drug may increase the risk of extrapyramidal symptoms (EPS) — movement-related side effects like stiffness, tremors, or restlessness.

Interactions Listed in the FDA-Approved Label

From the Serdexmethylphenidate and Dexmethylphenidate prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Monoamine oxidase inhibitors (MAOIs)
    What happensConcomitant use with CNS stimulants, including AZSTARYS, can cause hypertensive crisis, with potential outcomes including death, stroke, myocardial infarction, aortic dissection, ophthalmological complications, eclampsia, pulmonary edema, and renal failure.
    What to doDo not administer AZSTARYS concomitantly with MAOIs or within 14 days after discontinuing MAOI treatment.
  • Antihypertensive drugs
    What happensAZSTARYS may decrease the effectiveness of drugs used to treat hypertension.
    What to doMonitor blood pressure and adjust the dosage of the antihypertensive drug, as needed.
  • Halogenated anesthetics
    What happensConcomitant use may increase the risk of sudden blood pressure and heart rate increase during surgery.
    What to doAvoid use of AZSTARYS in patients being treated with anesthetics on the day of surgery.
  • What happensCombined use with methylphenidate when there is a change, increase or decrease, in dosage of either or both medications may increase the risk of extrapyramidal symptoms (EPS).
    What to doMonitor for signs of EPS.
Read the label’s full interactions text

7 DRUG INTERACTIONS Antihypertensive Drugs: Monitor blood pressure. Adjust dosage of antihypertensive drug as needed. 7.1 Clinically Important Interactions with AZSTARYS Table 1 presents clinically important drug interactions with AZSTARYS. Table 1: Clinically Important Drug Interactions with AZSTARYS Monoamine Oxidase Inhibitors (MAOIs) Clinical Impact Concomitant use of MAOIs and CNS stimulants, including AZSTARYS, can cause hypertensive crisis. Potential outcomes include death, stroke, myocardial infarction, aortic dissection, ophthalmological complications, eclampsia, pulmonary edema, and renal failure. Intervention Do not administer AZSTARYS concomitantly with MAOIs or within 14 days after discontinuing MAOI treatment Antihypertensive Drugs Clinical Impact AZSTARYS may decrease the effectiveness of drugs used to treat hypertension. Intervention Monitor blood pressure and adjust the dosage of the antihypertensive drug, as needed. Halogenated Anesthetics Clinical Impact Concomitant use of halogenated anesthetics and AZSTARYS may increase the risk of sudden blood pressure and heart rate increase during surgery. Intervention Avoid use of AZSTARYS in patients being treated with anesthetics on the day of surgery. Risperidone Clinical Impact Combined use of methylphenidate with risperidone when there is a change, whether an increase or decrease, in dosage of either or both medications, may increase the risk of extrapyramidal symptoms (EPS). Intervention Monitor for signs of EPS.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not take Azstarys if you are allergic to serdexmethylphenidate, methylphenidate, or any ingredient in the capsule.
  • Do not take Azstarys if you are currently taking an MAOI or have taken one within the past 14 days.
  • Tell your doctor if you have any heart problem, including structural abnormalities, arrhythmias, coronary artery disease, or cardiomyopathy — Azstarys may not be appropriate.
  • Tell your doctor if you have a personal or family history of bipolar disorder, depression, psychosis, or suicidal thoughts.
  • Tell your doctor if you or a family member has a history of motor or verbal tics or Tourette's syndrome.
  • Tell your doctor if you have glaucoma or elevated eye pressure — Azstarys requires extra caution and monitoring in these patients.
  • Pregnancy: There are no well-controlled studies of Azstarys in pregnant women. CNS stimulants may reduce blood flow to the placenta. Discuss the risks and benefits with your doctor; a National Pregnancy Registry is available at 1-866-961-2388.
  • Breastfeeding: Dexmethylphenidate may pass into breast milk. Monitor breastfed infants for agitation, poor appetite, or slow weight gain, and discuss with your doctor whether to continue.
  • Children under 6: Azstarys is not approved or recommended for this age group.
  • Discuss your personal risk of substance misuse or addiction with your prescriber before starting Azstarys.

Overdose

Taking too much Azstarys can cause serious, life-threatening effects including rapid or irregular heartbeat, very high or low blood pressure, agitation, confusion, hallucinations, seizures, dangerously high body temperature, and in severe cases, coma or death. If you suspect an overdose, call the Poison Help line at 1-800-222-1222 or go to an emergency room immediately — and tell providers all medications taken, since multiple drug ingestion is possible.

Half-Life and How Your Body Processes It

Serdexmethylphenidate is absorbed from the gut and converted to dexmethylphenidate mainly in the lower gastrointestinal tract, with the active drug reaching peak blood levels in about 2 hours under fasted conditions — slightly longer (4 to 4.5 hours) when taken with food. The prodrug itself has very low direct oral bioavailability (less than 3%), ensuring most activity comes from dexmethylphenidate. Dexmethylphenidate has a half-life of about 11.7 hours, meaning it takes roughly that long for the body to clear half of it, and steady-state levels are reached after about three days of once-daily dosing. The drug is primarily broken down (metabolized) into an inactive compound called ritalinic acid and excreted mostly through the urine.

Storage

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from moisture. Dispense in tight container (USP).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Serdexmethylphenidate and Dexmethylphenidate

From the licensed clinical database we use, rolled up per supplement, most serious first.

91 supplements and herbal products have documented interactions with Serdexmethylphenidate and Dexmethylphenidate in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 10Major
  • 67Moderate
  • 14Minor

See the other 83

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Serdexmethylphenidate and Dexmethylphenidate: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Serdexmethylphenidate and Dexmethylphenidate — the kind of thing our pharmacy team would talk through with you at the counter.

What exactly does Azstarys do, and why was I prescribed it?

Azstarys is a prescription stimulant approved to treat ADHD in people 6 and older. It works by boosting two brain chemicals — dopamine and norepinephrine — that are involved in attention, impulse control, and focus. Your prescriber chose it to help manage those ADHD symptoms. It's taken once daily in the morning and is designed to provide effects throughout the day.

Can I open the capsule if I (or my child) have trouble swallowing it?

Yes — Azstarys capsules can be opened and the contents sprinkled into 2 tablespoons of applesauce or 50 mL of water. Just make sure to consume the whole mixture right away, within 10 minutes. Don't save any of it for later, and don't split the dose. This option works just as well as swallowing the capsule whole.

What side effects should I watch out for vs. what's okay to just ride out?

The most common side effects are decreased appetite, trouble sleeping, stomach upset, and a slight rise in heart rate or blood pressure — these are usually manageable and often improve with time. You should call your doctor or seek care right away if you notice chest pain, hallucinations, extreme mood changes, prolonged or painful erections, or numbness and color changes in your fingers or toes. In children, check in with the doctor if growth seems slower than expected.

Is this medication addictive? I'm worried about taking a controlled substance.

That's a very reasonable concern, and it's important to talk about honestly. Azstarys is a controlled stimulant with a real potential for abuse and addiction — the FDA has its strongest warning about this. That said, when taken exactly as prescribed and monitored by your doctor, many people use it safely. The key is to take only your prescribed dose, never share it, and store it securely. Tell your prescriber right away if you feel like you need more than prescribed or feel like you can't stop.

Are there medications or supplements I need to avoid while taking Azstarys?

The most critical interaction is with a class of antidepressants called MAOIs — combining them with Azstarys can cause a dangerous spike in blood pressure that can be life-threatening. You need at least a 14-day gap between an MAOI and Azstarys. Azstarys can also reduce how well blood pressure medications work, and it should be avoided on the day of surgery involving certain anesthetics. Always share your full medication and supplement list with your prescriber and pharmacist.

Is it safe to take Azstarys during pregnancy or while breastfeeding?

There isn't a lot of direct safety data for Azstarys specifically in pregnancy. CNS stimulants can affect blood flow to the placenta, so the decision to continue treatment during pregnancy should be made carefully with your doctor. There is a pregnancy registry you can enroll in by calling 1-866-961-2388. If you're breastfeeding, the active ingredient may pass into breast milk, so watch your baby for signs like unusual fussiness, poor feeding, or slow weight gain, and keep your doctor in the loop.

Is serdexmethylphenidate and dexmethylphenidate available over the counter?

No. Serdexmethylphenidate and dexmethylphenidate is a prescription medicine: every serdexmethylphenidate and dexmethylphenidate product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

Is serdexmethylphenidate and dexmethylphenidate a controlled substance?

Yes — serdexmethylphenidate and dexmethylphenidate is a federally controlled substance (Schedule II) in the United States, so how it is prescribed, refilled and dispensed is regulated by the DEA.

When was serdexmethylphenidate and dexmethylphenidate first available?

The earliest FDA record we hold for serdexmethylphenidate and dexmethylphenidate is from 2021: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when serdexmethylphenidate and dexmethylphenidate was first used.

What is the brand name of serdexmethylphenidate and dexmethylphenidate?

Serdexmethylphenidate and dexmethylphenidate is the generic name. Its brand name is Azstarys.

What is the generic name of Azstarys?

The generic name of Azstarys is serdexmethylphenidate and dexmethylphenidate. A generic name is the name of the active ingredients, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is serdexmethylphenidate and dexmethylphenidate?

Serdexmethylphenidate and dexmethylphenidate belongs to the drug class Central Nervous System Stimulant, its established pharmacologic class on the FDA label.

What strengths does serdexmethylphenidate and dexmethylphenidate come in?

Serdexmethylphenidate and dexmethylphenidate is listed in the FDA's National Drug Code Directory in these forms and strengths. Capsule (by mouth): 26.1 mg/5.2 mg, 39.2 mg/7.8 mg and 52.3 mg/10.4 mg. A listing does not mean every pharmacy stocks every strength.

How much does serdexmethylphenidate and dexmethylphenidate cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $14.39 to $14.41 per capsule of brand-name Azstarys across 3 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Where can I read the serdexmethylphenidate and dexmethylphenidate prescribing information (package insert)?

The full FDA-approved prescribing information for serdexmethylphenidate and dexmethylphenidate, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Commave Sub, LLC's, revised May 11, 2026, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Serdexmethylphenidate and Dexmethylphenidate

Skip the scrolling. Ask in your own words and get an answer from Serdexmethylphenidate and Dexmethylphenidate’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Serdexmethylphenidate and Dexmethylphenidate’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Serdexmethylphenidate and Dexmethylphenidate on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Serdexmethylphenidate and Dexmethylphenidate Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Serdexmethylphenidate and Dexmethylphenidate Forms and Strengths (How It Comes)

Serdexmethylphenidate and Dexmethylphenidate comes in 1 dose form, the capsule. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Serdexmethylphenidate and Dexmethylphenidate inactive ingredients by manufacturer.

Capsule

By mouth
Brands Azstarys (the first brand, 2021)
How this form is used
What it may be used for
  • Azstarys capsules are indicated for the treatment of ADHD in patients 6 years of age and older
  • Azstarys is not recommended for children under 6 years of age due to higher drug exposure and increased side effects in this age group
Important instructions
  • Azstarys capsules are taken once daily in the morning, with or without food
  • Azstarys capsules may be swallowed whole, or opened and the full contents sprinkled into 50 mL of water or over 2 tablespoons of applesauce — consume the mixture immediately or within 10 minutes; do not store it
  • Azstarys should not be substituted for other methylphenidate products on a milligram-per-milligram basis, as it has a different pharmacokinetic profile
  • If switching from another methylphenidate product to Azstarys, stop the previous medication and re-titrate using the Azstarys dosing schedule as directed by your prescriber
Available strengths 3 strengths
3 FDA-listed product records ⓘ

Serdexmethylphenidate and Dexmethylphenidate on the U.S. Market: Products, Makers and Brands

How Serdexmethylphenidate and Dexmethylphenidate appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 3 Serdexmethylphenidate and Dexmethylphenidate product records with the FDA, mostly as capsule; the earliest marketing or approval year on record is 2021. The one brand name in the directory today is Azstarys; the rest are generics.

1
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
3
FDA-listed product records ⓘ
2021
Earliest FDA record ⓘ

How Widely Serdexmethylphenidate and Dexmethylphenidate Is Used (Medicaid Data)

How many Serdexmethylphenidate and Dexmethylphenidate prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

170,163
Medicaid prescriptions filled (Q1–Q4 2025)
$70.1M paid by Medicaid, before rebates

How commonly is Serdexmethylphenidate and Dexmethylphenidate prescribed? Of the 1,682 medications we measure, Serdexmethylphenidate and Dexmethylphenidate ranks #422 by Medicaid prescriptions — more than 75% of them.

Where Serdexmethylphenidate and Dexmethylphenidate ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Serdexmethylphenidate and Dexmethylphenidate product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 7.8 mg / 39.2 mg oral capsule is the most-dispensed Serdexmethylphenidate and Dexmethylphenidate product — about 42% of these Medicaid prescriptions.

dexmethylphenidate 7.8 MG / serdexmethylphenidate 39.2 MG Oral Capsule Most dispensed

71,078 Medicaid prescriptions (Q1–Q4 2025) 42% of Serdexmethylphenidate and Dexmethylphenidate prescriptions shown $29.2M paid by Medicaid, before rebates ≈ $411 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2562191

dexmethylphenidate 10.4 MG / serdexmethylphenidate 52.3 MG Oral Capsule

61,787 Medicaid prescriptions (Q1–Q4 2025) 36% of Serdexmethylphenidate and Dexmethylphenidate prescriptions shown $25.6M paid by Medicaid, before rebates ≈ $415 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2562194

dexmethylphenidate 5.2 MG / serdexmethylphenidate 26.1 MG Oral Capsule

37,298 Medicaid prescriptions (Q1–Q4 2025) 22% of Serdexmethylphenidate and Dexmethylphenidate prescriptions shown $15.3M paid by Medicaid, before rebates ≈ $410 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2562187

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 3 of the 3 listed Serdexmethylphenidate and Dexmethylphenidate NDCs had Medicaid claims.

Compare Serdexmethylphenidate and Dexmethylphenidate Products

A representative set of FDA-listed product records for Serdexmethylphenidate and Dexmethylphenidate — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Capsule
SERDEXMETHYLPHENIDATE CHLORIDE 26.1 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 5.2 mg Oral Commave Sub, LLC NDA View NDC →
SERDEXMETHYLPHENIDATE CHLORIDE 39.2 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 7.8 mg Oral Commave Sub, LLC NDA View NDC →
SERDEXMETHYLPHENIDATE CHLORIDE 52.3 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 10.4 mg Oral Commave Sub, LLC NDA View NDC →

Showing 3 of 3 products — FDA National Drug Code Directory. See every product, package size and price: browse all 3 Serdexmethylphenidate and Dexmethylphenidate NDCs →

Serdexmethylphenidate and Dexmethylphenidate Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Serdexmethylphenidate and Dexmethylphenidate recalls since July 2021.

✅No Serdexmethylphenidate and Dexmethylphenidate recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Serdexmethylphenidate and Dexmethylphenidate in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.

Dose forms
1
Strengths
3
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Multiple ingredients (MIN) Serdexmethylphenidate and Dexmethylphenidate RxCUI 2562192
  1. Dose form (SCDF) Oral Capsule RxCUI 2562189
    In current FDA listings

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Serdexmethylphenidate and Dexmethylphenidate Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Serdexmethylphenidate and Dexmethylphenidate: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Nov 2023.

Strength

For brand-name Azstarys, the SERDEXMETHYLPHENIDATE CHLORIDE 26.1 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 5.2 mg capsule, pharmacies paid an average of $14.39 per capsule as of Nov 18, 2026, up 3.7% from $13.88 a year earlier.

What pharmacies pay now
$14.39
per capsule, as of Nov 18, 2026
Last 4 weeks
No change
from $14.40 on Oct 21, 2026
Last 12 months
Up 3.7%
from $13.88 on Nov 19, 2025
Lowest and highest since Nov 2023
$12.82 to $14.44
per capsule

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Azstarys SERDEXMETHYLPHENIDATE CHLORIDE 26.1 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 5.2 mg capsule: the average pharmacy price per capsule, the last survey of each month
MonthPharmacy price
Nov 2026$14.39
Oct 2026$14.40
Sep 2026$14.40
Aug 2026$14.40
Jul 2026$14.41
Jun 2026$14.41
May 2026$14.40
Apr 2026$14.44
Mar 2026$14.44
Feb 2026$14.44
Jan 2026$14.44
Dec 2025$14.44
Nov 2025$13.88
Oct 2025$13.88
Sep 2025$13.91
Aug 2025$13.91
Jul 2025$13.91
Jun 2025$13.90
May 2025$13.91
Apr 2025$13.92
Mar 2025$13.92
Feb 2025$13.92
Jan 2025$13.92
Dec 2024$13.39
Nov 2024$13.38
Oct 2024$13.39
Sep 2024$13.39
Aug 2024$13.40
Jul 2024$13.40
Jun 2024$13.39
May 2024$13.40
Apr 2024$13.33
Mar 2024$13.33
Feb 2024$13.33
Jan 2024$13.33
Dec 2023$12.82
Nov 2023$12.82
FormStrengthVersion What pharmacies pay
Capsule · Oral SERDEXMETHYLPHENIDATE CHLORIDE 26.1 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 5.2 mg Azstarys (brand) $14.39 per capsule NDC details & price history
Capsule · Oral SERDEXMETHYLPHENIDATE CHLORIDE 39.2 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 7.8 mg Azstarys (brand) $14.41 per capsule NDC details & price history
Capsule · Oral SERDEXMETHYLPHENIDATE CHLORIDE 52.3 mg/1; DEXMETHYLPHENIDATE HYDROCHLORIDE 10.4 mg Azstarys (brand) $14.41 per capsule NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Serdexmethylphenidate and Dexmethylphenidate Brand Names

Serdexmethylphenidate and Dexmethylphenidate has one brand name on record: Azstarys. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Azstarys the first brand, 2021

Who Makes Serdexmethylphenidate and Dexmethylphenidate: Manufacturers and Labelers

One company lists Serdexmethylphenidate and Dexmethylphenidate products with the FDA. By number of product records, the largest are Commave Sub, LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Commave Sub, LLC 3

Sources for This Serdexmethylphenidate and Dexmethylphenidate Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated May 11, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Serdexmethylphenidate and Dexmethylphenidate.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
3
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
Commave Sub, LLC
Linked label effective
May 11, 2026
Composite sections available
25
Linked SPL Set ID
00b5e716-5564-4bbd-acaf-df2bc45a5663
Linked SPL Document ID
515506d2-5c3d-92d2-e063-6394a90a0603
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Commave Sub, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →